Sort
51,593 grants matching “hepatitis”
Clinical Center for Cholestatic Liver Disease in Children
$801,000Alexander Miethke · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · DK
Serum Organochlorine Levels and Primary Liver Cancer: A Nested Case-Control Study
$800,954Lawrence Stuart Engel · Sloan-Kettering Inst Can Research · R01 · FY2007 · ES
Gulf Longitudinal Follow-up (GuLF) Study
$800,822Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
CLINICAL IMPACT ON HCV &ALCOHOL IN HIV INFECTED PERSONS
$800,797Boston Medical Center · R01 · FY2002 · AA
Risk Factors for AIDS Among Intravenous Drug Users
$800,792Don C Des Jarlais · Beth Israel Medical Ctr (New York) · R01 · FY2006 · DA
COMPLEMENT AND CYTOKINE NETWORK IN LIVER REGENERATION
$800,726John D Lambris · University Of Pennsylvania · P01 · FY2010 · AI
RISK OF HEPATOCELLULAR CANCER AFTER VIROLOGICAL CURE WITH DIRECT ACTING ANTIVIRAL AGENTS IN INDIVIDUALS WITH HEPATITIS C
$800,660The General Hospital Corporation · · FY2019 · Defense Health Agency
Couples HIV Intervention Randomized Controlled Trial
$800,627National Development &Res Institutes · R01 · FY2004 · DA
ATECAR: Asian Training, Education on Cancer & Research
$800,580Grace X Ma · Temple Univ Of The Commonwealth · U01 · FY2006 · CA
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms
$800,521Michael J Sailor · University Of California, San Diego · R01 · FY2019 · AI
HBV Prevention for Homeless At-Risk for HBV/HCV/HIV
$800,506University Of California Los Angeles · R01 · FY2004 · DA
Cardiovascular Risk Reduction in an Aging HIV-Infected Population: The Impact of HCV Co-Infection
$800,488Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2023 · AG
Human Genetic determinants of HBV recovery
$800,431David L Thomas · Johns Hopkins University · R01 · FY2021 · AI
Developing Woodchucks Susceptible to Hepatitis B Virus Infection by Modifying the Virus or Host
$800,416Stephan Menne · Georgetown University · R01 · FY2025 · AI
Tissue-specific insulin resistance in obstructive sleep apnea: role of hypoxia
$800,400Jean-Marc Schwarz · University Of California, San Francisco · R01 · FY2018 · DK
Biomarkers for Steatohepatitis
$800,394Craig J McClain · University Of Louisville · RC2 · FY2009 · AA
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
$800,344Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2018 · DK
A systems immunology approach for predicting poor responses to Hepatitis B vaccination
$800,116Ramin Herati · New York University School Of Medicine · R01 · FY2023 · AI
Defining functional humoral correlates of immunity to guide vaccine design
$800,065Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2022 · AI
Pegylated Interferon +/- Ribavirin for Children with HCV
$800,000Johns Hopkins University · U01 · FY2005 · DK
Pegylated Interferon +/- Ribavirin for Children with HCV
$800,000Johns Hopkins University · U01 · FY2003 · DK
Pegylated Interferon +/- Ribavirin for Children with HCV
$800,000Johns Hopkins University · U01 · FY2004 · DK
Long-acting Antiviral Treatment for HBV
$799,938Rodney J.y. Ho · University Of Washington · R01 · FY2025 · AI
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$799,933Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Characterization of silently HBV-infected hepatocytes in HIV co-infection
$799,884Ashwin Balagopal · Johns Hopkins University · R01 · FY2019 · AI